期刊论文详细信息
Nutrition & Metabolism
Metabolic effects of milk protein intake strongly depend on pre-existing metabolic and exercise status
Loren Cordain4  Staffan Lindeberg1  Pedro Carrera-Bastos1  Swen Malte John2  Gerd Schmitz3  Bodo C Melnik2 
[1] Center for Primary Health Care Research, Lund University, Lund, Sweden;Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, Osnabrück, Germany;Institute of Clinical Chemistry and Laboratory Medicine, University Clinics of Regensburg, Regensburg, Germany;Department of Health and Exercise Science, Colorado State University, Fort Collins CO 80523, USA
关键词: Prostate cancer;    Obesity;    mTORC1;    microRNA;    Milk proteins;    Insulin resistance;    Glutaminolysis;    Branched-chain amino acids;    Body weight;    Adipogenesis;   
Others  :  803179
DOI  :  10.1186/1743-7075-10-60
 received in 2013-07-16, accepted in 2013-09-28,  发布年份 2013
PDF
【 摘 要 】

Milk protein intake has recently been suggested to improve metabolic health. This Perspective provides evidence that metabolic effects of milk protein intake have to be regarded in the context of the individual’s pre-existing metabolic and exercise status. Milk proteins provide abundant branched-chain amino acids (BCAAs) and glutamine. Plasma BCAAs and glutamine are increased in obesity and insulin resistance, but decrease after gastric bypass surgery resulting in weight loss and improved insulin sensitivity. Milk protein consumption results in postprandial hyperinsulinemia in obese subjects, increases body weight of overweight adolescents and may thus deteriorate pre-existing metabolic disturbances of obese, insulin resistant individuals.

【 授权许可】

   
2013 Melnik et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140708034828818.pdf 641KB PDF download
Figure 1. 119KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]McGregor RA, Poppitt SD: Milk protein for improved metabolic health: a review of the evidence. Nutr Metab (Lond) 2013, 10(1):46.
  • [2]Adibi SA: Influence of dietary deprivations on plasma concentrations of free amino acids of man. J Appl Physiol 1968, 25:52-57.
  • [3]Felig M, Cahill GF Jr: Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 1969, 281:811-816.
  • [4]Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, et al.: A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009, 9:311-326.
  • [5]Melnik BC, John SM, Schmitz G: Overstimulation of insulin/IGF-1 signaling by western diet may promote diseases of civilization: lessons learnt from Laron syndrome. Nutr Metab (Lond) 2011, 8:4.
  • [6]Melnik BC: Leucine signalling in the pathogenesis of type 2 diabetes and obesity. World J Diabetes 2012, 3(3):38-53.
  • [7]McCormack SE, Shaham O, McCarthy MA, Deik AA, Wang TJ, Gerszten RE, et al.: Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatr Obes 2013, 8(1):52-61.
  • [8]Morris C, O’Grada C, Ryan M, Roche HM, Gibney MJ, Gibney ER, et al.: The relationship between BMI and metabolomics profiles: a focus on amino acids. Proceed Nutr Soc 2012, 71:634-638.
  • [9]Lu J, Xie G, Jia W, Jia W: Insulin resistance and the metabolism of branched-chain amino acids. Front Med 2013, 7(1):53-59.
  • [10]Hoppe C, Molgaard C, Vaag A, Barkholt V, Michaelsen KF: High intakes of milk, but not meat, increase s-insulin and insulin resistance in 8-year-old boys. Eur J Clin Nutr 2005, 59(3):393-398.
  • [11]Lackey DE, Lynch CJ, Olson KC, Mostaedi R, Ali M, Smith WH, et al.: Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am J Physiol Endocrinol Metab 2013, 304(11):E1175-E1187.
  • [12]She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ: Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab 2007, 293:E1552-E1563.
  • [13]Mutch DM, Fuhrmann JC, Rein D, Wiemer JC, Bouillot JL, Poitou C: Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery. PLoS ONE 2009, 4(11):e7905.
  • [14]Laferrere B, Reilly D, Arias S, Swerdlow N, Gorroochurn P, Bawa B, et al.: Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese subjects despite identical weight loss. Sci TranlMed 2011, 3:80-82.
  • [15]Frühbeck G: Slow and fast dietary proteins. Nature 1998, 391:843-845.
  • [16]Lindeberg S, Eliasson M, Lindahl B, Ahrén B: Low serum insulin in traditional Pacific islanders – the Kitava study. Metabolism 1999, 48:1216-1219.
  • [17]Eaton SB, Konner M: Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med 1985, 313:283-289.
  • [18]Carrera-Bastos P, Fontes-Villabla M, O’Keefe JH, Lindeberg S, Cordain L: The western diet and lifestyle and diseases of civilization. Res Rep Clin Cardiol 2011, 2:15-35.
  • [19]Lindeberg S: Paleolithic diets as model for prevention and treatment of Western disease. Am J Hum Biol 2012, 24:110-115.
  • [20]Suryawan A, Davis TA: Regulation of protein synthesis by amino acids in muscle of neonates. Front Biosci 2012, 16:1445-1460.
  • [21]Yoshizawa F, Mochizuki S, Sugahara K: Differential dose response of mTOR signaling to oral administration of leucine in skeletal muscle and liver in rats. Biosci Biotech Biochem 2013, 77(4):839-842.
  • [22]Hornberger TA, Sukhija KB, Chien S: Regulation of mTOR by mechanically induced signaling events in skeletal muscle. Cell Cycle 2006, 5(13):1391-1396.
  • [23]Hornberger TA: Mechanotransduction and the regulation of mTORC1 signaling in skeletal muscle. Int J Biochem Cell Biol 2011, 43:1267-1276.
  • [24]Jacobs BL, You JS, Frey JW, Goodman CA, Gundermann DM, Hornberger TA: Eccentric contractions increase the phosphorylation of tuberous sclerosis complex-2 (TSC2) and alter the targeting of TSC2 and the mechanistic target of rapamycin to the lysosome. J Physiol 2013, 591:4611-4620.
  • [25]Jewell JL, Russell RC, Guan KL: Amino acid signalling upstream of mTOR. Nat Rev Mol Cell Biol 2013, 14:133-139.
  • [26]Kim SG, Buel GR, Blenis J: Nutrient regulation of the mTOR complex 1 signaling pathway. Mol Cells 2013, 35:463-473.
  • [27]Millward DJ, Layman DK, Tomé D, Schaafsma G: Protein quality assessment: impact of expanding understanding of protein and amino acid needs for optimal health. Am J Clin Nutr 2008, 87:1576S-1581S.
  • [28]Hall WL, Millward DJ, Long SJ, Morgan LM: Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 2003, 89(2):239-248.
  • [29]Boirie Y, Dangin M, Gachon P, Vasson MP, Maubois JL, Beaufrère B: Slow and fast dietary proteins differently modulate postprandial protein accretion. Proc Natl Acad Sci U S A 1997, 94(26):14930-14935.
  • [30]Farnfield MM, Carey KA, Gran P, Trenerry MK, Cameron-Smith D: Whey protein ingestion activates mTOR-dependent signalling after resistance exercise in young men: a double-blinded randomized controlled trial. Nutrients 2009, 1:263-275.
  • [31]Josse AR, Atkinson SA, Tarnopolsky MA, Phillips SM: Increased consumption of dairy foods and protein during diet- and exercise- induced weight loss promotes fat mass loss and lean mass in overweight and obese premenopausal women. J Nutr 2011, 141:1626-1634.
  • [32]Nilsson M, Holst JJ, Björck IE: Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks. Am J Clin Nutr 2007, 85:996-1004.
  • [33]DiGeorge AM, Auerbach VH, Mabry CC: Elevated serum insulin associated with leucine-induced hypoglycaemia. Nature 1960, 188:1036-1037.
  • [34]Loridan L, Sadeghi-Nejad A, Senior B: Hypersecretion of insulin after the administration of L-leucine to obese children. J Pediatr 1971, 78:53-58.
  • [35]Kalogeropoulou D, LaFave L, Schweim K, Gannon MC, Nuttall FQ: Leucine, when ingested with glucose, synergistically stimulates insulin secretion and lowers blood glucose. Metabolism 2008, 57:1747-1752.
  • [36]Johnson S, Karam JH, Levin SR, Grodsky GM, Forsham PH: Hyperinsulin response to oral leucine in obesity and acromegaly. J Clin Endocrinol Metab 1973, 37:431-435.
  • [37]Arnberg K, Mølgaard C, Michaelsen KF, Jensen SM, Trolle E, Larnkjær A: Skim milk, whey, and casein increase body weight and whey and casein increase the plasma C-peptide concentration in overweight adolescents. J Nutr 2012, 142:2083-2090.
  • [38]Shigeyama Y, Kobayashi T, Kido Y, Hashimoto N, Asahara SI, Matsuda T, et al.: Biphasic response of pancreatic β-cell mass to ablation of tuberous sclerosis complex 2 in mice. Mol Cell Biol 2008, 28:2971-2979.
  • [39]Wiley AS: Cow milk consumption, insulin-like growth factor-I, and human biology: a life history approach. Am J Hum Biol 2012, 24:130-138.
  • [40]Wiley AS: Dairy and milk consumption and child growth: is BMI involved? An analysis of NHANES 1999–2004. Am J Hum Biol 2010, 22:517-525.
  • [41]Berkey CS, Rockett HH, Willett WC, Colditz GA: Milk, dairy fat, dietary calcium, and weight gain. Arch Pediatr Adolesc Med 2005, 159:543-550.
  • [42]Barr SI, McCarron DA, Heany RP, Dawson-Highes B, Berga SL, Stern JS, et al.: Effects of increased consumption of fluid milk on energy and nutrient intake, body weight, and cardiovascular risk factors in healthy older adults. J Am Diet Assoc 2000, 100:810-817.
  • [43]Li X, Wang X, Liu R, Ma Y, Guo H, Hao L, et al.: Chronic leucine supplementation increases body weight and insulin sensitivity in rats on high-fat diet likely by promoting insulin signalling in insulin-target tissues. Mol Nutr Food Res 2013, 57(6):1067-1079.
  • [44]Dodd KM, Tee AR: Leucine and mTORC1: a complex relationship. Am J Physiol Endocrinol Metab 2012, 302:E1329-E1342.
  • [45]Foster KG, Fingar DC: Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J Biol Chem 2010, 285(19):14071-14077.
  • [46]Zoncu R, Efeyan A, Sabatini DM: mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011, 12:21-35.
  • [47]Fox HL, Pham PT, Kimball SR, Jefferson LS, Lynch CJ: Amino acid effects on translational repressor 4E–BP1 are mediated primarily by L-leucine in isolated adipocytes. Am J Physiol 1998, 275:C1232-C1238.
  • [48]Pham PT, Heydrick SJ, Fox HL, Kimball SR, Jefferson LS Jr, Lynch CJ: Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes. J Cell Biochem 2000, 79:427-441.
  • [49]Han JM, Jeong SJ, Park MC, Kim G, Kwon NH, Kim HK, et al.: Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 2012, 149:410-424.
  • [50]Yoon MS, Zhang C, Sun Y, Schoenherr CJ, Chen J: Mechanistic target of rapamycin (mTOR) controls homeostasis of adipogenesis. J Lipid Res 2013, 54(8):2166-2173.
  • [51]Wiley AS: Milk intake and total dairy consumption: associations with early menarche in NHANES 1999–2004. PLoS ONE 2011, 6:e14685.
  • [52]Chen L, Zhang C, Yeung E, Ye A, Mumford SL, Wactawski-Wende J, et al.: Age at menarche and metabolic markers for type 2 diabetes in premenopausal women: the BioCycle Study. J Clin Endocrinol Metab 2011, 96:E1007-E1012.
  • [53]Pierce MB, Kuh D, Hardy R: The role of BMI across the life course in the relationship between age at menarche and diabetes, in a British Birth Cohort. Diabet Med 2012, 29:600-603.
  • [54]Conway BN, Shu XO, Zhang X, Xiang YB, Cai H, Li H, et al.: Age at menarche, the leg length to sitting height ratio, and risk of diabetes in middle-aged and elderly Chinese men and women. PLoS ONE 2012, 7:e30625.
  • [55]Dreyfus JG, Lutsey PL, Huxley R, Pankow JS, Selvin E, Fernández-Rhodes L, et al.: Age at menarche and risk of type 2 diabetes among African-American and white women in the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 2012, 55:2371-2380.
  • [56]Stöckl D, Meisinger C, Peters A, Thorand B, Huth C, Heier M, et al.: Age at menarche and its association with the metabolic syndrome and its components: results from the KORA F4 study. PLoS ONE 2011, 6:e26076.
  • [57]Sindayikengera S, Xia WS: Nutritional evaluation of casein and whey proteins and their hydrolysates from Protamex. J Zhejiang Univ SCIENCE B 2006, 7(2):90-98.
  • [58]Carobbio S, Ishihara H, Fernandez-Pascual S, Bartley C, Martin-Del-Rio R, Maechler P: Insulin secretion profiles are modified by overexpression of glutamate dehydrogenase in pancreatic islets. Diabetologica 2004, 47:266-276.
  • [59]Yielding KL, Tomkins GM: An effect of L-leucine and other essential amino acids on the structure and activity of glutamic dehydrogenase. Proc Natl Acad Sci USA 1961, 47:983-989.
  • [60]Li M, Li C, Allen A, Stanley CA, Smith TJ: The structure and allosteric regulation of mammalian glutamate dehydrogenase. Arch Biochem Biophys 2012, 519(2):69-80.
  • [61]Wang X, Campbell LE, Miller CM, Proud CG: Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem J 1998, 334:261-267.
  • [62]Patti ME, Brambilla E, Luzi L, Landaker EJ, Kahn CR: Bidirectional modulation of insulin action by amino acids. J Clin Invest 1998, 101:1519-1529.
  • [63]Krebs M, Krssak M, Bernroider E, Anderwald C, Brehm A, Meyerspeer M, et al.: Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes 2002, 51:599-605.
  • [64]Tremblay F, Krebs M, Dombrowski L, Brehm A, Bernroider E, Roth E, et al.: Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 2005, 54:2674-2684.
  • [65]Tremblay F, Brulé S, Um SH, Masuda K, Roden M, Sun XJ, et al.: Identification of Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc Natl Acad Sci U S A 2007, 104:14056-14061.
  • [66]Shah OJ, Wang Z, Hunter T: Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 2004, 14:1650-1656.
  • [67]Melnik BC, John SM, Schmitz G: Milk is not just food but most likely a genetic transfection system activating mTORC1 signalling for postnatal growth. Nutr J 2013, 12:103.
  • [68]Pópulo H, Lopes JM, Soares P: The mTOR signalling pathway in human cancer. Int J Mol Sci 2012, 13:1886-1918.
  • [69]Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, et al.: The translational landscape of mTOR signaling steers cancer initiation and metastasis. Nature 2012, 485(7396):55-61.
  • [70]Melnik BC, John SM, Carrera-Bastos P, Cordain L: The impact of cow’s milk-mediated mTORC1-signalling in the initiation and progression of prostate cancer. Nutr Metab (Lond) 2012, 9(1):74.
  • [71]Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, Tjonneland A, et al.: Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 2008, 98:1574-1581.
  • [72]Song Y, Chavarro JE, Cao Y, Qiu W, Mucci L, Sesso HD, et al.: Whole milk intake is associated with prostate cancer-specific mortality among U.S. male physicians. J Nutr 2013, 143(2):189-196.
  • [73]Chen X, Gao C, Li H, Huang L, Sun Q, Dong Y, et al.: Identification and characterization of microRNAs in raw milk during different periods of lactation, commercial fluid, and powdered milk products. Cell Res 2010, 20:1128-1137.
  • [74]Izumi H, Kosaka N, Shimizu T, Sekine K, Ochiya T, Takase M: Bovine milk contains microRNA and messenger RNA that are stable under degradative conditions. J Dairy Sci 2012, 95:4831-4841.
  • [75]Izumi H, Kosala N, Shimizu T, Sekine K, Ochiya T, Takase M: Purification of RNA from milk whey. Methods Mol Biol 2013, 1024:191-201.
  • [76]Becker Buscaglia LE, Li Y: Apoptosis and the target genes of miR-21. Chin J Cancer 2011, 30:371-380.
  • [77]Kim YJ, Hwang SJ, Bae YC, Jung JS: Mir-21 regulates adipogenic differentiation through the modulation of TGF-β signalling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 2009, 27:3093-3102.
  • [78]Tate PL, Bibb R, Larcom LL: Milk stimulates growth of prostate cancer cells in culture. Nutr Cancer 2011, 63(8):1361-1366.
  • [79]Zhu H, Shyh-Chang N, Segrè AV, Shinoda G, Shah SP, Einhorn WS, et al.: The Lin28/let-7 axis regulates glucose metabolism. Cell 2011, 147:81-94.
  • [80]Frost RJ, Olson EN: Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proc Natl Acad Sci U S A 2011, 52:21075-21080.
  • [81]Grandison RC, Piper MDW, Partridge L: Amino acid imbalance explains extension of lifespan by dietary restriction in Drosophila. Nature 2009, 462(7276):1061-1064.
  • [82]Tartar M: The plate half-full: Status of research on the mechanisms of dietary restriction in Drosophila melanogaster. Exp Gerontol 2011, 46(5):363-368.
  • [83]Gallinetti J, Harputlugil E, Mitchell JR: Amino acid sensing in dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR. Biochem J 2013, 449(1):1-10.
  • [84]Kapahi P, Chen D, Rogers AN, Katewa SD, Li PW, Thomas EL, et al.: With TOR less is more. A key role for the conserved nutrient sensing TOR pathway in aging. Cell Metab 2010, 11(6):453-465.
  文献评价指标  
  下载次数:13次 浏览次数:9次